When lung cancer is too advanced to be cured, treatments can still help patients live longer and maintain a better quality of life.
2
目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。
Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).
3
背景与目的化疗在晚期非小细胞肺癌的治疗中具有极为重要的作用。
Background and objective Chemotherapy is very important in the treatment of advanced non-small cell lung cancer.